Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice

Clinical and Vaccine Immunology

Volumn 18, Issue 7, 2011, Pages 1083-1090

  Wallach, Michael G ^a   Webby, Richard J ^b   Islam, Fakhrul ^c   Walkden Brown, Stephen ^c   Emmoth, Eva ^d   Feinstein, Ricardo ^d   Gronvik, Kjell Olov ^d,e  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF NEW ENGLAND   (Australia)

^d NATIONAL VETERINARY INSTITUTE   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN Y ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLADISTICS; CONTROLLED STUDY; CROSS PROTECTION; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HEN; IMMUNOASSAY; IMMUNOPROPHYLAXIS; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ADMINISTRATION, INTRANASAL; ANIMALS; CHICKENS; CROSS PROTECTION; IMMUNOGLOBULINS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MICE; TREATMENT OUTCOME;

EID: 79960131189     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05075-11     Document Type: Article

References (16)

1. Carlander, D., J. Stalberg, and A. Larsson. 1999. Chicken antibodies a clinical chemistry perspective. Uppsala J. Med. Sci. 104:179-189.
2. De Jong, M. D., et al. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 353:2667-2672.
3. Gerhard, W., K. Mozdzanowska, and D. Zharikova. 2006. Prospects for universal influenza virus vaccine. Emerg. Infect. Dis. 12:569-574.
4. Hoffmann, E., A. S. Lipatov, R. J. Webby, E. A. Govorkova, and R. G. Webster. 2005. Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc. Natl. Acad. Sci. U. S. A. 102:12915-12920.
5. Karlsson, M., H. Kollberg, and A. Larsson. 2004. Chicken IgY: utilizing the evolutionary advantage. Worlds Poult. Sci. J. 60:341-347.
6. Kollberg, H., et al. 2003. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase 1 feasibility study. Pediatr. Pulmonol. 35:433-440.
7. Kubota-Koketsu, R., et al. 2009. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem. Biophys. Res. Commun. 387:180-185.
8. Lu, J., et al. 2006. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab′) 2 in mice. Respir. Res. 7:43-49.
9. Nguyen, H. H., et al. 2010. Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS One 5:e10152.
10. Okuno, Y., Y. Isegawa, F. Sasao, and S. Ueda. 1993. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67:2552-2558. (Pubitemid 23118850)
11. Reilly, M. R., R. Domingo, and J. Sandhu. 1997. Oral delivery of antibodies: future pharmacokinetic trends. Clin. Pharmacokinet. 32:313-323.
12. Shin, J.-H., et al. 2002. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin. Diagn. Lab. Immunol. 9:1061-1066.
13. Simmons, C. P., et al. 2007. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 4:928-936.
14. Sui, J., et al. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
15. Throsby, M., et al. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One 3:e3942.
16. Wallach, M., et al. 1995. Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine 13: 347-354.